FilingIndex
10-KThe Record

Ultragenyx Pharmaceutical Inc. files 10-K

Filed Feb 15, 2022 · 4y ago · Accession 0000950170-22-001284

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
RARE
CIK
1515673
Form type
10-K
Filing date
Feb 15, 2022
Report date
Dec 31, 2021
Document
rare-20211231.htm
Size
17.5 MB